Literature DB >> 26993876

Evaluation and management of peripheral venous and lymphatic malformations.

Naiem Nassiri1, Jones Thomas2, Nolan C Cirillo-Penn2.   

Abstract

The International Society for Study of Vascular Anomalies (ISSVA) broadly categorizes vascular anomalies as vascular tumors or vascular malformations. The latter are congenital lesions that are further categorized by their flow properties and include high-flow arteriovenous malformations, slow-flow venous and lymphatic malformations, and congenital mixed syndromes, which can include a combination of malformations. Unlike vascular tumors, vascular malformations never regress and can persist and grow for the duration of the patient's lifespan. As our understanding of the natural history, hemodynamics, and treatment outcomes of these lesions has expanded and evolved over the last few decades, certain fundamental diagnostic and therapeutic principles have been established and are considered standard of care. These overarching principles are crucial to adhere to in the overall management of these lesions and are highlighted and expanded on in this report, which focuses exclusively on peripheral slow-flow venous and lymphatic malformations.
Copyright © 2016 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 26993876     DOI: 10.1016/j.jvsv.2015.09.001

Source DB:  PubMed          Journal:  J Vasc Surg Venous Lymphat Disord


  2 in total

1.  Successful Complete Surgical Resection of a Large Venous Malformation of the Lower Extremity: A Case Report.

Authors:  Yohei Yamamoto; Tsuyoshi Ichinose; Masahiro Nakamura; Masato Nishizawa; Kimihiro Igari; Takahiro Toyofuku; Toshifumi Kudo; Yoshinori Inoue
Journal:  Ann Vasc Dis       Date:  2017-03-31

2.  When a lymphatic malformation determines a bowel volvulus: Are clinical status and images always reliable?

Authors:  Edoardo Guida; Massimo Di Grazia; Elisabetta Cattaruzzi; Rossana Bussani; Waifro Rigamonti; Maria Antonietta Lembo
Journal:  Int J Surg Case Rep       Date:  2016-06-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.